Padraig Dixon

发表

Protocol for an ‘efficient design’ cluster randomised controlled trial to evaluate a complex intervention to improve antibiotic prescribing for CHIldren presenting to primary care with acute COugh and respiratory tract infection: the CHICO study

J. Ingram, M. Gulliford, P. Dixon, 2021, BMJ Open.

A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial

T. Peters, R. Araya, C. Dowrick, 2017, Trials.

An evidence based approach to the use of telehealth in long-term health conditions: Development of an intervention and evaluation through pragmatic randomised controlled trials in patients with depression or raised cardiovascular risk

T. Fahey, C. Pope, A. O’Cathain, 2017 .

Care bundles to reduce re-admissions for patients with chronic obstructive pulmonary disease: a mixed-methods study

J. Benger, S. Purdy, C. Metcalfe, 2019, Health Services and Delivery Research.

Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial

C. Salisbury, S. Hollinghurst, A. Montgomery, 2016, BMJ Open.

Evaluation of ‘care bundles’ for patients with chronic obstructive pulmonary disease (COPD): a multisite study in the UK

J. Benger, S. Purdy, C. Metcalfe, 2019, BMJ Open Respiratory Research.

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation

William Hollingworth, Neil M Davies, Padraig Dixon, 2016, PharmacoEconomics.

Cost-effectiveness of telehealth for patients with depression: evidence from the Healthlines randomised controlled trial

C. Salisbury, S. Hollinghurst, A. Montgomery, 2016, BJPsych Open.

Effectiveness of an integrated telehealth service for patients with depression: a pragmatic randomised controlled trial of a complex intervention.

C. Pope, A. O’Cathain, J. Nicholl, 2016, The lancet. Psychiatry.

Cost-Consequence Analysis Alongside a Randomised Controlled Trial of Hospital Versus Telephone Follow-Up after Treatment for Endometrial Cancer

C. Sutton, P. Dixon, W. Hollingworth, 2018, Applied Health Economics and Health Policy.

Estimating the causal effect of liability to disease on healthcare costs using Mendelian Randomization.

G. Davey Smith, N. Davies, P. Dixon, 2022, Economics and human biology.

Estimating the causal effect of genetic liability to prevalent disease on hospital costs using Mendelian Randomization

G. Smith, N. Davies, P. Dixon, 2020, medRxiv.

Department of Economics Discussion Paper Series the Chinese Output Gap during the Reform Period 1978-2002 the Chinese Output Gap during the Reform Period 1978-2002 Table of Content Index of Tables and Figures Tables Potential Output

L. Yueh, Martín A. Rossi, G. Cameron, 2022 .

Mendelian randomization analysis of the causal impact of body mass index and waist-hip ratio on rates of hospital admission

P. Dixon, K. Wade, R. Richmond, 2021, Economics and human biology.

Assessing the causal impact of adiposity variation on rates of hospital admission: Application of Mendelian randomization

P. Dixon, K. Wade, R. Richmond, 2020, medRxiv.

The Association Between Adiposity and Inpatient Hospital Costs in the UK Biobank Cohort

G. Davey Smith, P. Dixon, W. Hollingworth, 2018, bioRxiv.

Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial

T. Fahey, C. Pope, A. O’Cathain, 2016, British Medical Journal.

Mendelian Randomization analysis of the causal effect of adiposity on hospital costs

G. Davey Smith, N. Davies, P. Dixon, 2020, Journal of health economics.

Developing decision support tools incorporating personalised predictions of likely visual benefit versus harm for cataract surgery: research programme

J. Sterne, P. Scanlon, P. Dixon, 2022, Programme Grants for Applied Research.

Cost-effectiveness of rapid laboratory-based mass-spectrometry diagnosis of bloodstream infection: evidence from the RAPIDO randomised controlled trial

P. Dixon, W. Hollingworth, K. Pike, 2021, BMJ Open.

Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients

P. Dixon, W. Hollingworth, J. Sparrow, 2020, Quality of Life Research.

Mapping to Quality of Life and Capability Measures in Cataract Surgery Patients: From Cat-PROM5 to EQ-5D-3L, EQ-5D-5L, and ICECAP-O Using Mixture Modelling

P. Dixon, W. Hollingworth, J. Sparrow, 2020, MDM policy & practice.

Cost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trial

C. Salisbury, S. Hollinghurst, P. Dixon, 2016, BMJ Open.

Feasibility cluster randomised controlled trial of a within-consultation intervention to reduce antibiotic prescribing for children presenting to primary care with acute respiratory tract infection and cough

T. Peters, S. Hollinghurst, J. Ingram, 2017, BMJ Open.

Quantifying the causal impact of biological risk factors on healthcare costs

P. Natarajan, A. Ganna, S. Jukarainen, 2022, medRxiv.

The causal effects of health conditions and risk factors on social and socioeconomic outcomes: Mendelian randomization in UK Biobank

J. Tyrrell, M. Munafo, S. Katikireddi, 2019, International journal of epidemiology.

Long-term cost-effectiveness of interventions for obesity: A mendelian randomisation study

N. Davies, P. Dixon, L. Howe, 2021, PLoS medicine.

Robust causal inference for long-term policy decisions: cost effectiveness of interventions for obesity using Mendelian randomization

H. Jones, N. Davies, P. Dixon, 2020, medRxiv.

The causal effect of adiposity on hospital costs: Mendelian Randomization analysis of over 300,000 individuals from the UK Biobank

G. Smith, N. Davies, P. Dixon, 2019, bioRxiv.

Can primary care research be conducted more efficiently using routinely reported practice-level data: a cluster randomised controlled trial conducted in England?

J. Ingram, M. Gulliford, P. Dixon, 2022, BMJ Open.

Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT

T. Peters, R. Araya, G. Lewis, 2019, PharmacoEconomics - Open.

Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT

C. Dowrick, M. Munafo, C. Harmer, 2019 .

Effectiveness of an integrated telehealth service for patients with depression: a pragmatic randomised controlled trial of a complex intervention.

C. Pope, A. O’Cathain, J. Nicholl, 2016, The lancet. Psychiatry.

Study protocol for an evaluation of the effectiveness of ‘care bundles’ as a means of improving hospital care and reducing hospital readmission for patients with chronic obstructive pulmonary disease (COPD)

J. Benger, S. Purdy, C. Metcalfe, 2016, BMC Pulmonary Medicine.

Caring for Carers: Positive and Normative Challenges for Future Research on Carer Spillover Effects in Economic Evaluation

P. Dixon, J. Round, Padraig Dixon, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Generic and disease-specific estimates of quality of life in macular degeneration: mapping the MacDQoL onto the EQ-5D-3L

S. Wordsworth, H. Dakin, Padraig Dixon, 2016, Quality of Life Research.

The Economics of Intellectual Property: A Review to Identify Themes for Future Research

Padraig Dixon, P. Dixon, C. Greenhalgh, 2002 .

Causal Estimation of Long-term Intervention Cost-effectiveness Using Genetic Instrumental Variables: An Application to Cancer

S. Harrison, Padraig Dixon, R. M. Martin, 2024, Medical decision making : an international journal of the Society for Medical Decision Making.

Did It Matter That the Cancer Drugs Fund Was Not NICE? A Retrospective Review.

P. Dixon, W. Hollingworth, C. Chamberlain, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.